Genetic biomarker linked to subcutaneous growth hormone dose-response
The interindividual variability of response to subcutaneously applied protein-based drugs remains poorly understood. However, defining genetic markers that can be associated with biological effects of such drugs may improve the understanding of individual variability of response and even drug resistance.
Genetic biomarker linked to subcutaneous growth hormone dose-response...

ASPS Addresses Concerns Regarding BOTOX Treatments
The American Society of Plastic Surgeons (ASPS) addressed concerns regarding the use of botulinum toxin products and adverse events following a recent petition from a consumer group. On January 23, Public Citizen requested the U.S. Food and Drug Administration (FDA) implement labeling changes and a written communication to
ASPS Addresses Concerns Regarding BOTOX Treatments...

Skin-Lightening Cremes Sold On Black Market Have Serious Health Risks
A Clinical Picture described in the February 16, 2008 issue of TheLancet underlines the perils of using skin lightening creams sold onthe black market. Dr. Tricia Tan and Dr. Tony Goldstone of theEndrocrine Unit in the Department of Investigative Medicine, ImperialCollege Healthcare NHSTrust, Hammersmith Hospital, London, UK, were
Skin-Lightening Cremes Sold On Black Market Have Serious Health Risks...

Gene Responsible For Statin-induced Muscle Pain Identified
Statins, the popular class of drugs used to lower cholesterol, are among the most commonly prescribed medications in developed countries. But for some patients, accompanying side effects of muscle weakness and pain become chronic problems and, in rare cases, can escalate to debilitating and even life-threatening damage. Now
Gene Responsible For Statin-induced Muscle Pain Identified...